Medical Cannabis Brief

TGA – Australia: Independent Expert Panel on MDMA and psilocybin – Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions

Cannabis Law Report

OCTOBER 5, 2021

We had some great news last week! Following Mind Medicine Australia’s applications to the TGA to reschedule MDMA and psilocybin for the treatment of key mental health disorders, the TGA have just released the Independent Review on the therapeutic value, benefits and risks of these medicines. Tags: medicines scheduling.

Treatment

Treatment Conditions Medicine Clinical Trials

Elon Musk and Other Successful People Who Use Cannabis

PrestoDoctor

SEPTEMBER 21, 2018

The news has been all over the press with some mocking the billionaire’s newfound fondness for cannabis, while others celebrate his stepping out. Regardless of where you stand, it got us thinking of all the successful people who use cannabis and why Elon Musk is far from a new thing. We’re kidding. Of course you have.

Vaping

Vaping Cannabis Sativa Recreational

FDA Gathers Public Social Media Data To Better Understand Cannabis Users As Part Of Its Effort Toward Rescheduling Marijuana

Medical Marijuana Program Connection

FEBRUARY 20, 2024

The Food and Drug Administration recently offered a glimpse into its comprehensive analysis justifying its recommendation to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act.

Media

Media Data Marijuana Food

TGA – Australia: Independent Expert Panel on MDMA and psilocybin – Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions

Elon Musk and Other Successful People Who Use Cannabis

FDA Gathers Public Social Media Data To Better Understand Cannabis Users As Part Of Its Effort Toward Rescheduling Marijuana

Stay Connected